An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

BACKGROUND: This study focuses on genetically stratified subgroups of Parkinson’s disease patients (PD) with an enrichment of risk variants in mitochondrial genes,who might benefit from treatment with the “mitochondrial enhancer” coenzyme Q10 (156 mg coenzyme Q10/d [QuinoMit Q10® Fluid] over six mon...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neurol Res Pract
Main Authors: Prasuhn, Jannik, Brüggemann, Norbert, Hessler, Nicole, Berg, Daniela, Gasser, Thomas, Brockmann, Kathrin, Olbrich, Denise, Ziegler, Andreas, König, Inke R., Klein, Christine, Kasten, Meike
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Clinical Trial Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650116/
https://ncbi.nlm.nih.gov/pubmed/33324897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-019-0033-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker